4DMedical Limited (4DX.AX)
AUD 0.46
(1.11%)
AUD 0.46
(1.11%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 5.12 Million AUD | -0.35% |
| 2023 | 5.13 Million AUD | -17.64% |
| 2022 | 6.23 Million AUD | 269.44% |
| 2021 | 1.68 Million AUD | -89.76% |
| 2020 | 16.48 Million AUD | 449.6% |
| 2019 | 3 Million AUD | 200.0% |
| 2018 | 1 Million AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q4 | 5.12 Million AUD | 0.0% |
| 2024 Q1 | 3.9 Million AUD | -23.96% |
| 2024 Q2 | 19.23 Million AUD | 392.25% |
| 2024 Q3 | - AUD | -100.0% |
| 2024 FY | 5.12 Million AUD | -0.35% |
| 2023 Q3 | 4.2 Million AUD | -26.29% |
| 2023 FY | 5.13 Million AUD | -17.64% |
| 2023 Q4 | 5.13 Million AUD | 22.19% |
| 2023 Q2 | 5.7 Million AUD | 25.29% |
| 2023 Q1 | 4.55 Million AUD | -27.0% |
| 2022 Q1 | 676.2 Thousand AUD | -59.96% |
| 2022 FY | 6.23 Million AUD | 269.44% |
| 2022 Q4 | 6.23 Million AUD | 21.41% |
| 2022 Q3 | 5.13 Million AUD | 295.6% |
| 2022 Q2 | 1.29 Million AUD | 92.1% |
| 2021 FY | 1.68 Million AUD | -89.76% |
| 2021 Q2 | 780.22 Thousand AUD | 90.32% |
| 2021 Q1 | 409.96 Thousand AUD | -97.51% |
| 2021 Q3 | 965.35 Thousand AUD | 23.73% |
| 2021 Q4 | 1.68 Million AUD | 74.94% |
| 2020 Q4 | 16.48 Million AUD | -6.72% |
| 2020 Q1 | 16.7 Million AUD | 456.71% |
| 2020 FY | 16.48 Million AUD | 449.6% |
| 2020 Q2 | 16.52 Million AUD | -1.05% |
| 2020 Q3 | 17.67 Million AUD | 6.96% |
| 2019 FY | 3 Million AUD | 200.0% |
| 2019 Q4 | 3 Million AUD | 0.0% |
| 2019 Q3 | 3 Million AUD | 0.0% |
| 2019 Q1 | - AUD | 0.0% |
| 2018 FY | 1 Million AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Adherium Limited | 93.2 Thousand AUD | -5393.92% |
| Aroa Biosurgery Limited | 6.81 Million AUD | 24.882% |
| Atomo Diagnostics Limited | 84.67 Thousand AUD | -5947.724% |
| Anteris Technologies Ltd | 2.33 Million AUD | -119.495% |
| Control Bionics Limited | 961.73 Thousand AUD | -432.433% |
| CardieX Limited | 3.22 Million AUD | -58.643% |
| Compumedics Limited | 6.97 Million AUD | 26.607% |
| Cochlear Limited | 243.7 Million AUD | 97.899% |
| CleanSpace Holdings Limited | 3.44 Million AUD | -48.583% |
| Cyclopharm Limited | 4.22 Million AUD | -21.132% |
| EMVision Medical Devices Ltd | 2.9 Million AUD | -76.554% |
| Nova Eye Medical Limited | 3.34 Million AUD | -52.9% |
| HeraMED Limited | 260.65 Thousand AUD | -1864.508% |
| Imricor Medical Systems, Inc. | 15.7 Million AUD | 67.388% |
| ImpediMed Limited | 1.14 Million AUD | -347.997% |
| InhaleRx Limited | 560.27 Thousand AUD | -813.945% |
| LBT Innovations Limited | 1.74 Million AUD | -193.781% |
| Micro-X Limited | 4.05 Million AUD | -26.279% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | 70.67 Thousand AUD | -7145.597% |
| PolyNovo Limited | 15.38 Million AUD | 66.706% |
| Respiri Limited | 1.17 Million AUD | -335.217% |
| SomnoMed Limited | 1.01 Million AUD | -403.99% |
| Universal Biosensors, Inc. | 4.97 Million AUD | -3.0% |
| Uscom Limited | 989.27 Thousand AUD | -417.611% |
| Visioneering Technologies, Inc. | 312.15 Thousand AUD | -1540.4% |